Proven Medical Device Executive Joins Cytovale to Drive Commercial Growth of the Company’s IntelliSep® Rapid Sepsis Detection Technology
, /PRNewswire/ — Cytovale®, a commercial-stage medical diagnostics company, today announced the appointment of Dave Vort as its new chief commercial officer. With more than 25 years of experience in the medical device sector, he will lead commercialization and market expansion as the company addresses dramatically growing demand for its artificial intelligence (AI)-enabled U.S. Food and Drug Administration (FDA)-cleared rapid sepsis detection solution, IntelliSep®.
“With our latest $100 million funding and strong interest in IntelliSep, Cytovale is solidifying its position as a leader in providing hospitals with essential tools to swiftly address and treat the life-threatening condition of sepsis,” said Ajay Shah, Cytovale co-founder and CEO. “Expanding our team with top-tier expertise is crucial as we continue to grow our presence in hospitals and emergency departments nationwide. Dave’s proven track record in commercializing …